A Phase 3, Long-Term, Randomized, Double-Blind, Placebo-Controlled trial of Troriluzole in Adult Subjects with Spinocerebellar Ataxia

Administered By

Awarded By

Contributors

Start/End

  • July 3, 2019 - December 31, 2022